By Lucy Tang January 25 , 2010An elementary school removes dictionaries due to the "oral sex" entry.
An elementary school removes dictionaries due to the "oral sex" entry.
The following maintenance therapies were also permitted if their use had been stable for ≥4 weeks prior to study entry: oral sustained-release theophylline, inhaled corticosteroids, and oral or parenteral corticosteroids (prednisone ≤10 mg per day or ≤20 mg every other day).
Patients taking oral prednisolone at entry continued as needed.
Overall, 98/207 subjects (47.3%) had used a contraceptive method in the 3 months prior to study entry: oral contraceptives (45 women, 21.7%), barrier methods (43 women, 20.8%), other methods (10 subjects, 4.8%).
The eligible patients were grouped into one of the two treatment cohorts according to the route of administration of the AD medication taken at the study entry: oral (donepezil, galantamine, rivastigmine, or memantine) or transdermal (rivastigmine).
The VADT randomized 1,791 participants with type 2 diabetes uncontrolled on insulin or maximal dose oral agents (median entry A1C 9.4%) to a strategy of intensive glycemic control (goal A1C <6.0%) or standard glycemic control, with a planned A1C separation of at least 1.5%.
VADT randomized 1,791 participants with type 2 diabetes uncontrolled on insulin or maximal-dose oral agents (median entry A1C 9.4%) to a strategy of intensive glycemic control (goal A1C <6.0%) or standard glycemic control, with a planned A1C separation of at least 1.5%.
The VADT randomized participants with type 2 diabetes uncontrolled on insulin or maximal dose oral agents (median entry A1C 9.4%) to a strategy of intensive glycemic control (goal A1C <6.0%) or standard glycemic control, with a planned A1C separation of at least 1.5%.
However, the ORIGIN study, an RCT of insulin glargine versus standard care in persons ranging from prediabetic to taking two oral agents at entry, is useful in being of relatively high exposure, having sizeable participant numbers followed for a median of 6.2 years, and having adjudicated cancer outcomes (41).
VADT randomized participants with type 2 diabetes who were uncontrolled on insulin or maximal-dose oral agents (median entry A1C 9.4%) to a strategy of intensive glycemic control (goal A1C <6.0%) or standard glycemic control, with a planned A1C separation of at least 1.5%.
